Synthetic cannabis ban in NSW from 1st of July

NewsGuard 100/100 Score

Kronic and other named synthetic drugs that induce effects similar to cannabis will be banned in NSW from July 1. NSW Mental Health Minister Kevin Humphries announced this saying use of the products sold online and at retail outlets have led to warnings from doctors. He added that the state government will ban the products under existing legislation.

Synthetic cannabis has been sold under the brand names Kronic, Spice, Kaos, Voodoo, Mango and Northern Lights and have a cannabis-like effect when smoked. It is known that they can impair a person's judgment, creating hazards when an affected person operates machinery or drives a vehicle. But more worryingly they say the products can be 10 times stronger than conventional marijuana and therefore carry an even higher risk of inducing paranoia and anxiety. While there is no reliable research into Kronic, experts have said it was known to contain high-potency cannabinoids, which can lead to schizophrenia.

Mr. Humphries said in his statement, “It is important to understand that these are not soft or recreational herbal products, they represent a real danger to an affected person's safety and wellbeing.” He added that he has discussed the matter with the state Attorney-General Greg Smith SC, who advised that the products could be banned under the NSW Drug Misuse and Trafficking Act. Therefore, they would be prohibited under the same category as cannabis, heroin and cocaine.

Sale of the products will be banned from July 1, with retailers required to arrange for destruction of any unsold quantities after that date. A ban on the use of synthetic cannabis will come into effect seven days later. Penalties for supplying the drug are expected to match those for cannabis.

Western Australia has recently banned the products with other states and territories announcing that they too are considering outlawing synthetic cannabis. South Australia followed suit soon afterwards, but gave no notice of its intentions because of concerns people would stockpile the drugs. Other states, including Queensland and Tasmania, have also indicated they intend to act soon to ban the products.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Synthetic cannabis ban in NSW from 1st of July. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/20110628/Synthetic-cannabis-ban-in-NSW-from-1st-of-July.aspx.

  • MLA

    Mandal, Ananya. "Synthetic cannabis ban in NSW from 1st of July". News-Medical. 24 April 2024. <https://www.news-medical.net/news/20110628/Synthetic-cannabis-ban-in-NSW-from-1st-of-July.aspx>.

  • Chicago

    Mandal, Ananya. "Synthetic cannabis ban in NSW from 1st of July". News-Medical. https://www.news-medical.net/news/20110628/Synthetic-cannabis-ban-in-NSW-from-1st-of-July.aspx. (accessed April 24, 2024).

  • Harvard

    Mandal, Ananya. 2018. Synthetic cannabis ban in NSW from 1st of July. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/20110628/Synthetic-cannabis-ban-in-NSW-from-1st-of-July.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Heavy cannabis use linked to increased risk of developing a new anxiety disorder